$Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK$

Imminent fracture risk amongst new users of oral bisphosphonates in actual practice settings: A multi-national European cohort study from Denmark, Spain, and the UK

Bibliographic Details
Main Authors:	Khalid, S, Ernst, M, Javaid, M, Cooper, C, Delmestri, A, Martinez-Laguna, D, Toth, E, Prieto-Alhambra, D
Format:	Conference item
Published:	Springer 2019

Similar Items

Imminent (1- and 2-year) fracture risk following a first (sentinel) fracture: a multinational European cohort study including over 700,000 participants from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2019)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a mutli-national study including data from Denmark, Spain, and the UK
by: Khalid, S, et al.
Published: (2018)

Predicting imminent fractures in patients with a recent fracture or starting oral bisphosphonate therapy: development and international validation of prognostic models
by: Khalid, S, et al.
Published: (2021)

Imminent fracture risk assessments in the UK FLS setting: implications and challenges
by: Pinedo-Villanueva, R, et al.
Published: (2019)

Secular trends in the initiation of therapy in secondary fracture prevention: widening treatment gaps in Denmark and Spain
by: Prieto-Alhambra, D, et al.
Published: (2018)

Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK
by: Pineda-Moncusí, M, et al.
Published: (2022)

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
by: Skjødt, MK, et al.
Published: (2020)

The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications
by: Skjødt, MK, et al.
Published: (2021)

The national treatment gap in secondary fracture prevention in Denmark 2005-2014: individual patient data including both hospital administered and all prescribed anti osteoporosis medications
by: Skjødt, MK, et al.
Published: (2019)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
by: Oda, T, et al.
Published: (2021)

Comparative fracture risk amongst users of different anti-osteoporosis therapies: meta-analysis of propensity-matched cohort studies using data from the Clinical Practice Research Datalink (UK) and SIDIAP (Spain).
by: Khalid, S, et al.
Published: (2017)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
by: Robinson, D, et al.
Published: (2018)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
by: Garriga, C, et al.
Published: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
by: Garriga, C, et al.
Published: (2017)

Oral bisphosphonate use and latent class trajectories of kidney function: A cohort study
by: Strauss, V, et al.
Published: (2018)

Anti-osteoporosis medication prescriptions and incidence of secondary fracture amongst hip fracture patients in England and Wales: an age stratified interrupted time series analysis
by: Hawley, S, et al.
Published: (2018)

Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK
by: Martín-Merino, E, et al.
Published: (2017)

Use of oral bisphosphonates and bone mineral density changes in moderate-severe (Stage 3B+) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark
by: Ali, M, et al.
Published: (2017)

Comparative fracture risk amongst users of different anti-osteoporosis drugs available in the UK in the NHS: A propensity-matched cohort study using data from the Clinical Practice Research Datalink
by: Khalid, S, et al.
Published: (2016)

Comparative risk of venous thromboembolism amongst users of different anti-osteoporosis drugs in the uk: a propensity-matched cohort study using data from the clinical practice research datalink
by: Khalid, S, et al.
Published: (2016)

The association between calcium ± vitamin D supplementation and fracture risk among incident users of oral bisphosphonates: a population-based cohort study
by: Reyes, C, et al.
Published: (2015)

Comparative risk of venous thromboembolism among users of different anti-osteoporosis drugs in the UK National Health Service and in Catalonia, Spain: A propensity-matched cohort study
by: Khalid, S, et al.
Published: (2017)

Characterization of polypharmacy in middle-aged and elderly adults in the UK: an analysis of 0.5 million people in UK Biobank
by: Xie, J, et al.
Published: (2021)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
by: Shah, A, et al.
Published: (2016)

Two-fold regional variation in initiation of anti-osteoporosis medication after hip fracture in the UK
by: Shah, A, et al.
Published: (2016)

Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: A UK parallel cohort study using CPRD
by: Hawley, S, et al.
Published: (2020)

PREDICTORS OF INADEQUATE RESPONSE TO ORAL BISPHOSPHONATE THERAPY: A POPULATION-BASED COHORT STUDY
by: Round, G, et al.
Published: (2012)

The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease
by: Ali, M, et al.
Published: (2018)

Risk of venous thromboembolism amongst users of different antiosteoporosis drugs: a multinational population-based cohort study
by: Martin-Merino, E, et al.
Published: (2016)

Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study
by: Shah, A, et al.
Published: (2016)

Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
by: Martin-Merino, E, et al.
Published: (2016)

Oral bisphosphonate use and risk of acute kidney injury, gastrointestinal events and hypocalcaemia in patients with moderate-advanced chronic kidney disease: a population-based cohort study
by: Ali, MS, et al.
Published: (2017)

BISPHOSPHONATE USE IS ASSOCIATED WITH REDUCED REVISIONS OF LOWER LIMB JOINT (KNEE OR HIP) ARTHROPLASTY: A POPULATION-BASED COHORT STUDY
by: Prieto-Alhambra, D, et al.
Published: (2011)

A PREDICTIVE TOOL FOR ORAL BISPHOSPHONATE THERAPY DISCONTINUATION WITHIN INCIDENT USERS: A POPULATION-BASED COHORT STUDY
by: Round, G, et al.
Published: (2012)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study.
by: Prieto-Alhambra, D, et al.
Published: (2011)

Oral bisphosphonates and chronic kidney disease: progression and safety
by: Prieto-Alhambra, D, et al.
Published: (2018)

Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study
by: Robinson, DE, et al.
Published: (2021)